MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC. (a subsidiary of Medical International Technology USA) specializes in the development, manufacturing and marketing of needle free jet injectors for veterinary (AGRO-JET ®) and human (MED-JET ®) applications.
Our experience in the research and development of needle-free jet injectors dates back to 1978 and has enabled us to develop unique delivery systems.
Our technologies give us a competitive edge in that, unlike other types of needle-free injectors available on the market, MIT's injectors are designed to function with low air pressure without compromising on accuracy, convenience and ease of use. Medical International Technologies' injectors are fully patented and are currently sold to veterinarians and integrators in Canada, USA, Australia, Asia and Europe.
Our Mission is to provide the veterinary and human medical communities with state of the art delivery system that ensures comfort to the patient, safety to the environment, ease of use and affordability to the user.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renown pharmaceutical companies, universities and physicians in veterinary and human medicine.
|MIT'S patented technology offers a unique delivery system for medications vital to the livestock, companion & small animal and poultry industries. |
The AGRO-JET® is a semi-automatic, high performance, needle free jet injector specifically designed for the livestock, poultry and small & companion animal industries. The AGRO-JET® can deliver medications of from 0.1 to 5 cm3 at speeds of 600 to 3,000 injections an hour - a much higher amount than other existing needle-free injectors. The system's fine adjustability allows extremely precise dosage delivery, while the high absorption rate can result in a medication savings of up to 15 percent.
The difference between MIT's AGRO-JET® needle free jet injection system from other systems is its ability to utilize low pressure delivery methods without compromising accuracy, convenience and ease of use - while ensuring patient comfort, environmental safety and user affordability.
Less pain and stress
Reduces tissue damage
Provides high absorption rate
No biological waste
Highly cost effective
Significant time savings
No cross contamination
Allows intradermal, subcutaneous or intra-muscular injections
The AGRO-JET® offers a range of features:
- Automatic, semi-automatic or manual operation
- Powered by CO2 (gas pressure) or compressed air, most ideal for situations calling for mass or multiple injections in animals.
- The CO2 canister is conveniently carried on the back in a specially designed harness bag, freeing the hands and allowing for free movements and can be carried everywhere around your pigpen or farm.
AVAILABLE IN ELEVEN DIFFERENT MODELS WITH FIXED OR ADJUSTABLE DOSES
TESTED FOR EFFICACY BY THE STATE UNIVERSITY OF NORTH CAROLINA
SCHERING PLOUGH ANIMAL HEALTH
OTHER STUDIES ARE ONGOING IN VARIOUS COUNTRIES
AGRO-JET Brochure: http://www.mitcanada.ca/ResearchDev/pdf/Agro-Jet%20ENGLISH.pdf
Adaptation of that same patented delivery system as the AGROJET ®, for human use, is completed and tested and will offer a rapid and extremely safe solution for mass vaccine injections. This need is increasingly probable given the spread of infectious diseases in many parts of the world especially in third world countries as well as with the surging of new diseases and the threat of worldwide bioterrorism. MIT’s injectors are designed for intra-dermal, subcutaneous and intra-muscular injections. Like the AGRO-JET®, the vaccine or medication being injected with the MED-JET® is directed through a small orifice 7 times smaller than the smallest available needle in the world. This extremely small stream of liquid under pressure will pierce the skin and then the remainder of the dose will be dispersed into the desired layer of tissue. The system's uniqueness is its ability to utilize low pressure delivery methods without compromising accuracy, convenience and ease of use - while ensuring patient comfort, environmental safety and user affordability.
MED-JET Brochure: http://www.mitcanada.ca/ResearchDev/pdf/Med-Jet%20MBX%20ENGLISH.pdf
POINTS OF DISTRIBUTION
Medical International Technology, Inc.
1872 Beaulac Street
Montreal, PQ HR4 2E7
Karim Menassa, President, CEO
Michel Bayouk, Secretary
Estimated Market Cap
$947,053 as of Oct 22, 2008
27,058,663 as of Jun 30, 2008
|10QSB ||Aug 14, 2008 ||Jun 30, 2008 |
|10QSB ||May 14, 2008 ||May 12, 2008 |
|10QSB ||Feb 8, 2008 ||Dec 31, 2007 |
|Feb 8, 2010 ||OTCMarketBulls: OTCMarketbulls.com Reports Hot Market Movers For February 8, 2010 - Medical International Technology Inc. (OTCBB: MDLH) +27.50%, One World Ventures, Inc. (OTC: OWVI) +18.92%, Bebida Beverage Company, Inc. (OTC: BBDA) +50%, Implant Sciences Corporation (OTCBB: IMSC) +14.29% |
|Feb 8, 2010 ||Medical International Technology (MIT) Inc. targeting a multi-billion dollar market with 3 new products |
|Feb 6, 2010 ||Medical International Technology (MIT) Inc. - Corporate Update |
|Feb 4, 2010 ||Mr. Harold Gervais nominated to MIT's Advisory Board and appointed as Vice-President and Chief Financial Officer |
|Jan 28, 2010 ||MIT is pleased to announce the nomination of Mr. Jacques Gauthier and Mr. Michel Carrier to its newly formed Advisory Board |
|Jan 14, 2010 ||MIT is pleased to announce that it has received clearance by FINRA to be listed on the OTC Bulletin Board "MDLH.OB" |